GLP‐1 receptor agonists have also been shown to alleviate ER stress, support β‐cell survival, and reduce neurodegeneration in rodent and human preclinical models of Wolfram syndrome (Gorgogietas et al. 2023; Kondo et al. 2018; Seppa et al. 2019). Here, GLP1R is linked to Wolfram syndrome.